HomeCompareAKBTY vs MRK

AKBTY vs MRK: Dividend Comparison 2026

AKBTY yields 2.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $33.3K in total portfolio value
10 years
AKBTY
AKBTY
● Live price
2.57%
Share price
$3.03
Annual div
$0.08
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.5K
Annual income
$303.12
Full AKBTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AKBTY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAKBTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AKBTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AKBTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKBTY
Annual income on $10K today (after 15% tax)
$218.30/yr
After 10yr DRIP, annual income (after tax)
$257.65/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,070.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKBTY + MRK for your $10,000?

AKBTY: 50%MRK: 50%
100% MRK50/50100% AKBTY
Portfolio after 10yr
$40.1K
Annual income
$5,050.63/yr
Blended yield
12.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AKBTY
No analyst data
Altman Z
-0.2
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKBTY buys
0
MRK buys
0
No recent congressional trades found for AKBTY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAKBTYMRK
Forward yield2.57%2.76%
Annual dividend / share$0.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$23.5K$56.8K
Annual income after 10y$303.12$9,798.13
Total dividends collected$2.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AKBTY vs MRK ($10,000, DRIP)

YearAKBTY PortfolioAKBTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,957$256.83$11,206$366.19$249.00MRK
2$11,987$262.99$12,650$502.35$663.00MRK
3$13,095$268.89$14,407$694.19$1.3KMRK
4$14,286$274.53$16,585$967.82$2.3KMRK
5$15,566$279.90$19,342$1,363.89$3.8KMRK
6$16,940$285.03$22,913$1,947.19$6.0KMRK
7$18,416$289.91$27,662$2,823.89$9.2KMRK
8$20,000$294.54$34,159$4,173.35$14.2KMRK
9$21,699$298.95$43,337$6,308.80$21.6KMRK
10$23,521$303.12$56,776$9,798.13$33.3KMRK

AKBTY vs MRK: Complete Analysis 2026

AKBTYStock

Akbank T.A.S., together with its subsidiaries, provides various banking products and services in Turkey and internationally. It operates through: Retail Banking; Commercial Banking, SME Banking, Corporate-Investment and Private Banking; and Treasury segments. The company's retail banking services comprise deposit accounts, retail loans, commercial installment loans, credit cards, insurance products, and asset management services, as well as bank cards, investment funds trading, automatic payment, foreign currency trading, safe deposit box rental, cheques, money transfer, investment banking, and telephone and internet banking. It also offers services to large, medium, and small size corporate and commercial customers that include Turkish Lira (TL) and foreign currency denominated working capital loans financing for investments, foreign trade financing, derivative instruments for hedging purposes of foreign currency and interest risk, letters of credit, foreign currency trading, corporate finance, and deposit and cash management services, as well as project finance loans; and timely and permanent solutions for corporate customers' working capital management, delivering cash management services based on customers' requests that include collection and payment services and liquidity and information management. In addition, the company engages in treasury activities consisting of TL and foreign currency spot and forward transactions, treasury and government bonds, Eurobonds, and private sector bond transactions, as well as derivative trading activities; and marketing and pricing activities related treasury products. Further, it provides financial leasing services, stock exchange brokerage services, and portfolio management, as well as offers payment services and issues electronic money. As of December 31, 2021, the company operated 710 branches. Akbank T.A.S. was founded in 1948 and is headquartered in Istanbul, Turkey.

Full AKBTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AKBTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKBTY vs SCHDAKBTY vs JEPIAKBTY vs OAKBTY vs KOAKBTY vs MAINAKBTY vs JNJAKBTY vs ABBVAKBTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.